Last updated on April 2019

Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip


Brief description of study

The primary objective of the study is to describe the safety and tolerability of fasinumab, including adverse events of special interest (AESIs), in patients with pain due to radiographically-confirmed OA of the knee or hip.

Clinical Study Identifier: NCT02683239

Find a site near you

Start Over

Regeneron Investigational Site

Birmingham, AL United States
  Connect »

Regeneron Investigational Site

Little Rock, AR United States
  Connect »

Regeneron Investigational Site

Beverly Hills, CA United States
  Connect »

Regeneron Investigational Site

San Diego, CA United States
  Connect »

Regeneron Investigational Site

San Marcos, CA United States
  Connect »

Regeneron Investigational Site

Colorado Springs, CO United States
  Connect »

Regeneron Investigational Site

Littleton, CO United States
  Connect »

Regeneron Investigational Site

Clearwater, FL United States
  Connect »

Regeneron Investigational Site

Pinellas Park, FL United States
  Connect »

Regeneron Investigational Site

Evansville, IL United States
  Connect »

Regeneron Investigational Site

Kansas City, KS United States
  Connect »

Regeneron Investigational Site

Frederick, MD United States
  Connect »

Regeneron Investigational Site

Worcester, MA United States
  Connect »

Regeneron Investigational Site

Richfield, MN United States
  Connect »

Regeneron Investigational Site #1

Saint Louis, MO United States
  Connect »

Regeneron Investigational Site #2

Saint Louis, MO United States
  Connect »

Regeneron Investigational Site

Las Vegas, NV United States
  Connect »

Regeneron Investigational Site

High Point, NC United States
  Connect »

Regeneron Investigational Site

Cincinnati, OH United States
  Connect »

Regeneron Investigational Site

Oklahoma City, OK United States
  Connect »

Regeneron Investigational Site

Duncansville, PA United States
  Connect »

Regeneron Investigational Site

San Antonio, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.